logo
Market closedLast updated 14 JUL 2026, 16:08 ISTData NSENot investment advice
Vimta Labs

Vimta Labs Share Price Today (VIMTALABS)

NSE: VIMTALABSBSE 524394HealthcareHealthcare Research Analytics & Technologyvimta.com
TechnicalsTV Chart
₹553.05
3.25−0.58%
Overall Score65/100
Today's 547
₹553.05
563
52-Week 376
₹553.05
903
Open555.00
Prev Close556.30
Bid553.02100
Ask553.08100

TODAY IN ONE LINE

Closed at ₹553.05 (−0.58%); delivery 45.9%. Market opens 9:15 IST. · as of 16:08 IST

With a market cap of ₹2,469.1 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume118.9K−56%vs 20D avg
Market Cap₹2,469.1 Cr.
Promoter Hold.35.85%
Face Value₹2
Fwd P/E—
PEG1.98
EV/EBITDA10.49
P/S6.1
ROA12.19%
Beta1.04
Div Payout17.26%
THE STOCK SCORE

How good is this company?

Overall performance across 5 key dimensions.

Overall Score65/100
Updated 11 Jul
Each card tappable → shows formula + inputs
FLAGS

Vimta Labs flags 

Key strengths and potential risks.

🚩 1 red flag✅ 7 green flags

Green Flags

  • ●Earnings GrowthEPS (TTM) grew by a solid 14.3% YoY
  • ●Quarterly OutperformanceLatest quarter Sales up 20.6% and Profit up 43.0%
  • ●High Capital EfficiencyROCE of 17.6% indicating pricing power
  • ●Strong Return on EquityHealthy ROE of 18.6%
  • ●Healthy Operating MarginsOPM is structurally strong at 24.0%
  • ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • ●Rising Receivables vs SalesReceivables grew 20.1% outpacing sales growth of 19.3%
THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

09 JUL 2026
corporate
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Vimta Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Particip...
View PDF
🔒Prime: full history + alerts on this stock
Valuation

Vimta Labs Limited valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Vimta Labs Limited, framed against the sector median so the premium or discount is obvious at a glance.

Key MetricsLive · as of 14 Jul 2026
Valuation

Valuation

Market Cap
₹2,469.1 Cr.
P/E Ratio
—
P/B Ratio
—
EPS
₹17.38
Profitability

Profitability

ROE
Good
Better than threshold of 15%
18.55%
ROCE
Good
Better than threshold of 15%
17.6%
Net Margin
Good
Better than threshold of 10%
19.03%
Op Margin
Good
Better than threshold of 15%
24%
Growth

Growth

EPS YoY
Neutral
Near threshold of 15%
14.3%
Revenue YoY
Good
Better than threshold of 10%
16.5%
Qtr Sales
Good
Better than threshold of 10%
20.6%
Qtr Profit
Good
Better than threshold of 10%
43%
Financial Health

Financial Health

Debt / Equity
Good
Better than threshold of 1
0.01
Book Value
₹102.28
Div Yield
Neutral
Near threshold of 2%
0.54%
Promoter Holding
Neutral
Near threshold of 50%
35.85%
Technicals

Vimta Labs Limited technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Vimta Labs Limited — derived from the live tape, not yesterday's close.

Vimta Labs Limited last traded at ₹553.05 with an intraday range of ₹547.15–₹562.95 — live indicator, pivot and CPR signals below.

Last updated: 16:08:00 IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹553.05
LevelPrice (₹)Distance% Δ
R4593.22+40.17+7.26%
R3577.42+24.37+4.41%
R2570.18+17.13+3.10%
R1561.62+8.57+1.55%
PIVOT554.381.330.24%
CURRENT553.05——
S1545.82-7.23-1.31%
S2538.58-14.47-2.62%
S3530.02-23.03-4.16%
S4514.22-38.83-7.02%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 553.72P: 554.38TC: 555.05
R1
R2
R3
R4
indicator
LTP: 553.05
PDH: 567.00
PDL: 554.05
● Market Sentiment

VIMTALABS is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Average

● Opening Range

Day's range: ₹547.15–₹555

● Price Position

Trading Below opening range, showing Bearishness

Financials

Vimta Labs Limited financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Vimta Labs Limited, switchable between annual and quarterly views, consolidated or standalone.

Vimta Labs Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,469.1 Cr. and reported EPS of ₹17.38.

Period2018201920202021202220232024
Revenue from Operations
213
213
181
211
278
318
318
Other Income
2
2
3
1
1
3
4
Total Income
215
215
184
212
280
322
322
Cost of Goods Sold (COGS)
58
58
54
61
79
74
76
Gross Profit
154
154
127
150
199
244
242
+Operating Expenses
97
97
97
97
119
149
155
EBITDA
58
58
30
53
80
95
87
+Non-Operating Expenses
24
24
25
25
24
33
36
Profit Before Tax (PBT)
35
35
8
29
56
65
54
+Tax Expense
10
10
1
7
14
17
13
Total Profit for Period
25
25
7
21
41
48
41
Net Profit (Owner's PAT)
25
25
7
21
41
48
41
Earnings Per Share (EPS)
5.72
5.72
1.55
4.84
9.35
10.88
9.25
Diluted Shares Outstanding (Nos.)
4
4
4
4
4
4
4
+Additional Disclosures
237
237
229
244
303
330
344
Sales Growth %
—
0.00
-15.02
16.58
32.09
14.34
0.02
YoY Sales Growth %
—
0.00
-15.02
16.58
32.09
14.34
0.02
Material Cost %
28
28
30
28
28
23
24
Employee Cost %
28
28
34
29
27
29
31
Other Cost %
18
18
20
17
15
18
18
OPM %
27
27
17
25
29
30
27
Tax %
28
28
17
25
26
26
25
Profit Growth %
—
0.00
-72.96
212.71
93.09
16.55
-14.87
Gross Margin %
72.53
72.53
70.26
70.99
71.54
76.79
76.03
EBITDA Margin %
27.06
27.06
16.57
25.14
28.85
29.83
27.27
Interest Coverage Ratio
8.21
8.21
2.39
13.78
38.02
24.27
24.79
Ebit
38
38
9
30
57
64
53
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Vimta Labs segment analysis: revenue and profit mix.

Disclosed business segments at Vimta Labs with their share of revenue and profit, switchable between consolidated and standalone reporting.

Vimta Labs discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for Vimta Labs Limited.

Our AI distills the core fundamental drivers supporting Vimta Labs Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.

Vimta Labs Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Operating margin 26.20% significantly outpaces industry peers like INDGN and SYNGENE.

  • Low debt-to-equity ratio 0.0073 ensures exceptional financial flexibility and stability.

  • Latest quarterly EPS grew 15.3% YoY, demonstrating consistent earnings momentum.

  • TTM EPS grew 14.3% YoY with strong cash flow per share ₹32.94.

  • Stable promoter holding 35.85% reflects management commitment and governance confidence.

bear case

Key Risks.

  • P/E ratio 32.78x appears elevated relative to peer median around 16x.

  • Dividend yield 0.54% modest, limiting income appeal for yield-focused investors.

  • Negative free cash flow in FY24 Q3 (₹-15.54 Cr) raises near-term liquidity concerns.

  • High capex intensity with investing cash flow consistently negative across periods.

  • Market cap ₹2,390.70 Cr restricts institutional participation and liquidity depth.

flip conditions

Flip Conditions.

  • Exit if deal pipeline (TCV) shrinks or margin drops below historical averages.

  • Watch wage inflation and attrition rates — primary threats to operating leverage in IT.

  • Exit if ROE slips below 14%. The operating engine is no longer compounding capital efficiently.

Shareholding

Vimta Labs shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Vimta Labs — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Mar 2026

Promoters35.85%↓0.05%
Public59.12%↓0.29%
FII4.89%↑0.30%
DII0.14%↑0.03%

Ownership Distribution

Promoters
35.85%
Retail & Public
59.12%
Foreign Institutions
4.89%
Domestic Institutions
0.14%

Category Trends

Foreign Institutions Breakdown
Total Holding: 4.89%
Net Change: +0.30%
Category Total4.89%
Total Holding4.89%
Net Change+0.30%
Not Fully Disclosed

⚠️Partial Disclosure Notice

Individual institutions below total 2.27%, but category aggregate is 4.89%. Some institutions may not be disclosed by the company as per regulatory requirements.

Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
BARCA GLOBAL MASTER FUND, LP
2.27%
0.00%
0.00%
Mar 2026
Cassini Partners L.P. Managed by Habrok Capital Management LLP
0.00%
0.00%
0.00%
Mar 2026
Peers

Vimta Labs Limited peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Vimta Labs Limited is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Syngene International Limited
₹16,931.51 Cr
Best Profit Growth
Syngene International Limited
67.40 %
Highest Dividend Yield
Syngene International Limited
0.60 %

Peer Comparison

Company Name
INDGN
Indegene Limited
Compare vs INDGN
SUVEN
Suven Life Sciences Limited
Compare vs SUVEN
SYNGENE
Syngene International Limited
Compare vs SYNGENE
VIMTALABS
Vimta Labs LimitedCurrent Stock
09 · Chart Patterns

Vimta Labs Limited chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for Vimta Labs Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

  1. 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
  2. 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
  3. 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
  4. 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
  5. 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Detection
History
Click a pattern card to draw the pattern shape on the candles — labeled pivots (Head, Shoulders, Bottoms), neckline, breakout point, projection and invalidation. Click again to clear.
0 patterns
Historical accuracy
—
0 of 0 confirmed patterns reached projection
Avg move when projection reached
—
measured from break level
Avg sessions to projection
—
after confirmation
Best pattern on VIMTALABS
—
needs ≥3 completions

Pattern history — every completed pattern and its outcome

No completed patterns yet.
View full VIMTALABS pattern history & scanner →
Delivery Conviction

Vimta Labs Limited delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Vimta Labs Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Vimta Labs Limited stood at 45.9% of traded volume, against a 20-day average of 39.1%.

Avg Delivery (20D)39.1%+6.7 ppt latest vs avg
Highest Delivery50.7%on 06 Jul
Avg Volume (20D)2.73 L20-day run-rate
Conviction Trend↑ Strengthening+6.7 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

Vimta Labs announcements: results, concalls, ratings, M&A.

Filings Vimta Labs sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Vimta Labs files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 119 documents below.

  1. 09 Jul 2026Certificate under SEBI (Depositories and Participants) Regulations, 2018View PDF

    Certificate under SEBI (Depositories and Participants) Regulations, 2018

    Vimta Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  2. 04 Jul 2026UpdatesView PDF

    Updates

    Vimta Labs Limited has informed the Exchange regarding 'Update on Payment of Dividend'.

  3. 01 Jul 2026Allotment of SecuritiesView PDF

    Allotment of Securities

    Vimta Labs Limited has informed the Exchange regarding allotment of 17549 securities pursuant to ESOP/ESPS at its meeting held on July 01, 2026

  4. 30 Jun 2026Trading WindowView PDF

    Trading Window

    Vimta Labs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  5. 29 Jun 2026Disclosure under SEBI Takeover RegulationsView PDF

    Disclosure under SEBI Takeover Regulations

    Vimta Labs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…

§ 10b · Reports & Decks

Investor decks & rating reports.

Investor Presentations· 8
INV
Investor Presentation

Investor Presentation

06 May 2026✦ AI SummaryOpen →
INV
Investor Presentation

Investor Presentation

28 Jan 2026✦ AI SummaryOpen →
INV
Investor Presentation

Investor Presentation

03 Nov 2025✦ AI SummaryOpen →
INV
Investor Presentation

Investor Presentation

18 Jul 2025✦ AI SummaryOpen →
Credit Ratings· 1
CR
Credit Rating

Credit Rating

08 Aug 2025✦ AI SummaryOpen →
Corporate Actions

Vimta Labs dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Vimta Labs has declared, sequenced by announce and record date.

Vimta Labs corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

Insider Activity

Vimta Labs insider trading: promoter and management activity.

Promoter, director and designated-employee transactions in Vimta Labs as reported to SEBI — buying and selling signals from the people who know the business best.

Vimta Labs insider activity below tracks 9 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).

InsiderCategoryTxn DateActionQuantityValue (₹)Price
Jagadeesh KodaliInsider25 Feb 2026buy+5.0 K₹23.2 L₹464.00
Jagadeesh KodaliInsider25 Feb 2026buy+5.0 K₹23.2 L₹464.00
Jagadeesh KodaliInsider25 Feb 2026buy+5.0 K₹23.2 L₹464.00
VASIREDDI VEERABHADRA PRASADInsider28 May 2025sell−9.50 L₹92.76 Cr.₹976.40
SUJANI VASIREDDIInsider28 May 2025buy+3.50 L₹34.17 Cr.₹976.40
RAJYA LAKSHMI VASIREDDIInsider28 May 2025buy+6.00 L₹58.58 Cr.₹976.40
Harriman VungalInsider12 Feb 2025sell−2.9 K₹31.43 L₹1,083.66
Harriman VungalInsider06 Feb 2025sell−1.2 K——
Harriman VungalInsider06 Feb 2025sell−975₹10.12 L₹1,038.00
About the Company

About Vimta Labs Limited: business, sector, key facts.

What Vimta Labs Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Vimta Labs Limited operates in the Healthcare Research Analytics & Technology industry under the Healthcare sector, listed as NSE: VIMTALABS, BSE: 524394.

VIMTALABS
Healthcare

Vimta Labs Limited

NSE · VIMTALABS·BSE · 524394·vimta.com

Vimta Labs Limited is a prominent contract research and testing services provider operating both domestically in India and internationally. Their core business revolves around offering comprehensive support to a diverse range of industries, enabling them to streamline their research, development, and quality control processes.

A significant portion of Vimta Labs' services centers on the biopharmaceutical sector. They provide crucial support throughout the drug lifecycle, encompassing preclinical and clinical research phases, as well as analytical services. This allows biopharmaceutical companies to outsource complex research tasks, benefiting from Vimta's expertise and infrastructure.

Beyond pharmaceuticals, Vimta Labs caters to the needs of medical device companies by offering preclinical research and testing services. This ensures the safety and efficacy of medical devices before they reach the market. Their services extend to agrochemical and specialty chemical companies, assisting with contract research and testing critical for product development and regulatory compliance.

Food safety and quality assurance forms another important pillar of Vimta Labs' business. They provide comprehensive testing and analytical development services to a broad spectrum of stakeholders in the food industry, including manufacturers, processors, and regulatory bodies. This includes testing for various food products and materials.

Furthermore, Vimta Labs offers environmental regulatory services, crucial for industries facing environmental impact assessments and post-project monitoring requirements. This support extends to a wide range of sectors such as power, infrastructure, cement, oil and gas, and mining. They also provide EMI/EMC testing for electronic and electrical products and components.

In summary, Vimta Labs provides a broad portfolio of testing and research services across numerous sectors. Their diverse clientele includes those in agriculture, biologics, personal care, medical devices, specialty chemicals, food, electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, and environmental sectors. This wide-ranging expertise and established presence make Vimta Labs a significant player in the contract research and testing landscape.

company facts
Employees1,384
SectorHealthcare
HeadquartersHyderabad, India
Market Cap₹2,469.1 Cr.
Listed OnNSE
leadership17 on record
Dr. Sivalinga Prasad Vasireddi
Executive Chairman
Dr. Sivalinga Vasireddi
Executive Chairman of the Board
Dr. Upendra Bhatnagar
Senior Vice President of Preclinical
Mr. Harriman Vungal D.Tech
Executive Director of Operations, Member of Scientific Advisory Board & Executive Director
Mr. Purnachandra Gutta
Non-Executive Independent Director
Mr. Sanjay Dave
Non-Executive Independent Director
Mr. Satya Neerukonda
Executive Director
Mr. Satya Sreenivas Neerukonda
Executive Director
Mr. Siva Rama Krishna Kambhampati
Chief Financial Officer
Mrs. Sujani Vasireddi
Company Secretary, Compliance officer
Mr. Yadagiri Pendri
Non-Executive Independent Director
Ms. Harita Vasireddi
Managing Director, Executive Director

Related

Peers, sector trends, screeners and strategy playbooks contextual to this stock.

§ ∞ · Plainly Answered

Questions investors ask about Vimta Labs Limited (VIMTALABS).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Vimta Labs Limited (VIMTALABS)?

The current share price of Vimta Labs Limited (VIMTALABS) is ₹553.05. Today, the stock has declined by ₹3.25 (0.58%), trading in a range of ₹547.15 to ₹562.95. The stock opened at ₹555 with a trading volume of 1,18,919 shares.

02Is Vimta Labs Limited stock a good investment for long-term?

Vimta Labs Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,469.1 crores, P/E ratio of 0.00, ROE of 18.55%, and ROCE of 17.60%. The dividend yield stands at 0.54%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Vimta Labs Limited stock?

The 52-week high price of Vimta Labs Limited (VIMTALABS) is ₹902.65, while the 52-week low is ₹376.05. Currently trading at ₹553.05, the stock is 33.6% away from its 52-week low and 38.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Vimta Labs Limited stock at the current price?

Whether to buy Vimta Labs Limited stock at ₹553.05 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 0.00. Today's performance shows a loss of 0.58%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Vimta Labs Limited and when is the next dividend?

Vimta Labs Limited offers a dividend yield of 0.54%, which means for every ₹100 invested at the current price of ₹553.05, you can expect to receive approximately ₹0.54 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Vimta Labs Limited?

Vimta Labs Limited's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 0.00, ROE: 18.55%, ROCE: 17.60%, Dividend Yield: 0.54%, EPS: ₹17.38, Book Value: ₹102.28, and Debt-to-Equity: 0.01. The company's market cap stands at ₹2,469.1 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Vimta Labs Limited stock performing today in the market?

Vimta Labs Limited stock opened at ₹555 and is currently trading at ₹553.05, showing a decline of ₹3.25 (0.58%). The intraday high is ₹562.95 and low is ₹547.15. The trading volume stands at 1,18,919 shares, indicating moderate market participation today.

08What is the P/E ratio of Vimta Labs Limited and what does it indicate?

Vimta Labs Limited has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹17.38, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Vimta Labs Limited (VIMTALABS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.